Skip to main content
Journal cover image

Deep Learning-Based Fluence Map Prediction for Pancreas Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost.

Publication ,  Journal Article
Wang, W; Sheng, Y; Palta, M; Czito, B; Willett, C; Hito, M; Yin, F-F; Wu, Q; Ge, Y; Wu, QJ
Published in: Adv Radiat Oncol
2021

PURPOSE: Treatment planning for pancreas stereotactic body radiation therapy (SBRT) is a challenging task, especially with simultaneous integrated boost treatment approaches. We propose a deep learning (DL) framework to accurately predict fluence maps from patient anatomy and directly generate intensity modulated radiation therapy plans. METHODS AND MATERIALS: The framework employs 2 convolutional neural networks (CNNs) to sequentially generate beam dose prediction and fluence map prediction, creating a deliverable 9-beam intensity modulated radiation therapy plan. Within the beam dose prediction CNN, axial slices of combined structure contour masks are used to predict 3-dimensional (3D) beam doses for each beam. Each 3D beam dose is projected along its beam's-eye-view to form a 2D beam dose map, which is subsequently used by the fluence map prediction CNN to predict its fluence map. Finally, the 9 predicted fluence maps are imported into the treatment planning system to finalize the plan by leaf sequencing and dose calculation. One hundred patients receiving pancreas SBRT were retrospectively collected for this study. Benchmark plans with unified simultaneous integrated boost prescription (25/33 Gy) were manually optimized for each case. The data set was split into 80/20 cases for training and testing. We evaluated the proposed DL framework by assessing both the fluence maps and the final predicted plans. Further, clinical acceptability of the plans was evaluated by a physician specializing in gastrointestinal cancer. RESULTS: The DL-based planning was, on average, completed in under 2 minutes. In testing, the predicted plans achieved similar dose distribution compared with the benchmark plans (-1.5% deviation for planning target volume 33 V33Gy), with slightly higher planning target volume maximum (+1.03 Gy) and organ at risk maximum (+0.95 Gy) doses. After renormalization, the physician rated 19 cases clinically acceptable and 1 case requiring minor improvement. CONCLUSIONS: The DL framework can effectively plan pancreas SBRT cases within 2 minutes. The predicted plans are clinically deliverable, with plan quality approaching that of manual planning.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Adv Radiat Oncol

DOI

ISSN

2452-1094

Publication Date

2021

Volume

6

Issue

4

Start / End Page

100672

Location

United States

Related Subject Headings

  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wang, W., Sheng, Y., Palta, M., Czito, B., Willett, C., Hito, M., … Wu, Q. J. (2021). Deep Learning-Based Fluence Map Prediction for Pancreas Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost. Adv Radiat Oncol, 6(4), 100672. https://doi.org/10.1016/j.adro.2021.100672
Wang, Wentao, Yang Sheng, Manisha Palta, Brian Czito, Christopher Willett, Martin Hito, Fang-Fang Yin, Qiuwen Wu, Yaorong Ge, and Q Jackie Wu. “Deep Learning-Based Fluence Map Prediction for Pancreas Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost.Adv Radiat Oncol 6, no. 4 (2021): 100672. https://doi.org/10.1016/j.adro.2021.100672.
Wang W, Sheng Y, Palta M, Czito B, Willett C, Hito M, et al. Deep Learning-Based Fluence Map Prediction for Pancreas Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost. Adv Radiat Oncol. 2021;6(4):100672.
Wang, Wentao, et al. “Deep Learning-Based Fluence Map Prediction for Pancreas Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost.Adv Radiat Oncol, vol. 6, no. 4, 2021, p. 100672. Pubmed, doi:10.1016/j.adro.2021.100672.
Wang W, Sheng Y, Palta M, Czito B, Willett C, Hito M, Yin F-F, Wu Q, Ge Y, Wu QJ. Deep Learning-Based Fluence Map Prediction for Pancreas Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost. Adv Radiat Oncol. 2021;6(4):100672.
Journal cover image

Published In

Adv Radiat Oncol

DOI

ISSN

2452-1094

Publication Date

2021

Volume

6

Issue

4

Start / End Page

100672

Location

United States

Related Subject Headings

  • 3211 Oncology and carcinogenesis